淘气 发表于 2025-3-26 21:34:50

http://reply.papertrans.cn/23/2281/228069/228069_31.png

VICT 发表于 2025-3-27 02:13:29

http://reply.papertrans.cn/23/2281/228069/228069_32.png

高歌 发表于 2025-3-27 08:08:45

http://reply.papertrans.cn/23/2281/228069/228069_33.png

Silent-Ischemia 发表于 2025-3-27 12:02:14

http://reply.papertrans.cn/23/2281/228069/228069_34.png

Genistein 发表于 2025-3-27 15:05:04

http://reply.papertrans.cn/23/2281/228069/228069_35.png

Gudgeon 发表于 2025-3-27 21:07:47

http://reply.papertrans.cn/23/2281/228069/228069_36.png

Extort 发表于 2025-3-27 23:57:00

http://reply.papertrans.cn/23/2281/228069/228069_37.png

彩色的蜡笔 发表于 2025-3-28 04:32:56

Book 2008tion regarding pathologic and molecular classification of renal tumors. The neoplasms covered include clear cell carcinomas, papillary cancers, nonepithelial tumors, and other mass lesions that resemble tumors. The management of patients with renal cancer having localized or advanced disease are dis

萤火虫 发表于 2025-3-28 08:00:26

Renal Cell Carcinoma: ,,iagnosed in patients ranging from 40 to 70 years of age, with a male predominance of 1.6 to 1.0.. A comparison of 43,685 cases of renal cancer diagnosed in the period 1973 to 1985 with those diagnosed from 1986 to 1998 (Surveillance, Epidemiology, and End Results database) demonstrated a marg

Aqueous-Humor 发表于 2025-3-28 14:24:06

http://reply.papertrans.cn/23/2281/228069/228069_40.png
页: 1 2 3 [4] 5 6 7
查看完整版本: Titlebook: Clinical Management of Renal Tumors; Ronald M. Bukowski,Andrew C. Novick Book 2008 The Editor(s) (if applicable) and The Author(s), under